LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 101 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2017. The put-call ratio across all filers is 2.05 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $288,000 | -25.4% | 90,310 | -0.1% | 0.00% | – |
Q1 2022 | $386,000 | +9550.0% | 90,441 | +8944.1% | 0.00% | – |
Q3 2021 | $4,000 | +100.0% | 1,000 | +100.0% | 0.00% | – |
Q2 2021 | $2,000 | – | 500 | +861.5% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 52 | -99.8% | 0.00% | – |
Q3 2020 | $107,000 | -75.1% | 26,485 | -73.8% | 0.00% | – |
Q2 2020 | $430,000 | -91.8% | 100,985 | -92.0% | 0.00% | -100.0% |
Q1 2020 | $5,271,000 | +6.9% | 1,254,989 | -0.0% | 0.00% | 0.0% |
Q4 2019 | $4,932,000 | -86.2% | 1,255,018 | -69.1% | 0.00% | -75.0% |
Q3 2019 | $35,770,000 | -4.9% | 4,064,816 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $37,599,000 | +44.0% | 4,064,816 | +0.1% | 0.00% | +33.3% |
Q1 2019 | $26,115,000 | -29.6% | 4,061,425 | +3.3% | 0.00% | -40.0% |
Q4 2018 | $37,091,000 | -53.2% | 3,933,351 | -0.0% | 0.01% | -44.4% |
Q3 2018 | $79,184,000 | -25.8% | 3,933,641 | +7.5% | 0.01% | -25.0% |
Q2 2018 | $106,694,000 | -0.6% | 3,657,684 | +1.5% | 0.01% | -7.7% |
Q1 2018 | $107,288,000 | +0.4% | 3,602,698 | +8.5% | 0.01% | 0.0% |
Q4 2017 | $106,895,000 | -7.4% | 3,321,786 | +0.1% | 0.01% | -7.1% |
Q3 2017 | $115,418,000 | +17.0% | 3,318,518 | +0.2% | 0.01% | +16.7% |
Q2 2017 | $98,637,000 | +0.3% | 3,313,318 | +0.6% | 0.01% | 0.0% |
Q1 2017 | $98,339,000 | +104.9% | 3,294,435 | +20.3% | 0.01% | +100.0% |
Q4 2016 | $47,999,000 | -26.3% | 2,738,101 | 0.0% | 0.01% | -33.3% |
Q3 2016 | $65,139,000 | +55.4% | 2,738,101 | +4.5% | 0.01% | +50.0% |
Q2 2016 | $41,925,000 | -24.5% | 2,620,326 | -1.3% | 0.01% | -25.0% |
Q1 2016 | $55,509,000 | -24.9% | 2,654,659 | -3.0% | 0.01% | -20.0% |
Q4 2015 | $73,878,000 | -0.4% | 2,736,226 | +2.5% | 0.01% | -9.1% |
Q3 2015 | $74,203,000 | +32.3% | 2,670,126 | +16.7% | 0.01% | +57.1% |
Q2 2015 | $56,070,000 | +60.7% | 2,287,626 | +20.0% | 0.01% | +75.0% |
Q1 2015 | $34,883,000 | +70.8% | 1,906,167 | +72.2% | 0.00% | +33.3% |
Q4 2014 | $20,418,000 | +92.0% | 1,106,641 | 0.0% | 0.00% | +200.0% |
Q3 2014 | $10,635,000 | +140.6% | 1,106,641 | +129.8% | 0.00% | 0.0% |
Q2 2014 | $4,421,000 | +91.6% | 481,641 | +125.5% | 0.00% | – |
Q1 2014 | $2,307,000 | – | 213,573 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,138,893 | $123,256,000 | 18.11% |
Broadfin Capital, LLC | 1,656,720 | $49,337,000 | 7.69% |
SECTORAL ASSET MANAGEMENT INC | 1,128,219 | $33,598,000 | 3.68% |
Perceptive Advisors | 4,313,611 | $128,459,000 | 3.60% |
RTW INVESTMENTS, LP | 1,122,540 | $33,429,000 | 3.18% |
Asymmetry Capital Management, L.P. | 55,864 | $1,664,000 | 2.08% |
EMORY UNIVERSITY | 77,335 | $2,303,000 | 1.64% |
Monashee Investment Management LLC | 185,000 | $5,509,000 | 1.52% |
SPHERA FUNDS MANAGEMENT LTD. | 260,000 | $7,743,000 | 1.18% |
Stanley-Laman Group, Ltd. | 167,825 | $4,998,000 | 1.14% |